A citation-based method for searching scientific literature

Somayeh Vafaei, Angelina O Zekiy, Ramadhan Ado Khanamir, Burhan Abdullah Zaman, Arman Ghayourvahdat, Hannaneh Azimizonuzi, Majid Zamani. Cancer Cell Int 2022
Times Cited: 6







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy.
Patrícia Figueiredo, Anni Lepland, Pablo Scodeller, Flavia Fontana, Giulia Torrieri, Mattia Tiboni, Mohammad-Ali Shahbazi, Luca Casettari, Mauri A Kostiainen, Jouni Hirvonen,[...]. Acta Biomater 2021
29
33

Cancer immunotherapy using checkpoint blockade.
Antoni Ribas, Jedd D Wolchok. Science 2018
33

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Tony S K Mok, Yi-Long Wu, Iveta Kudaba, Dariusz M Kowalski, Byoung Chul Cho, Hande Z Turna, Gilberto Castro, Vichien Srimuninnimit, Konstantin K Laktionov, Igor Bondarenko,[...]. Lancet 2019
33

Enterocolitis due to immune checkpoint inhibitors: a systematic review.
Emilie Soularue, Patricia Lepage, Jean Frederic Colombel, Clelia Coutzac, David Faleck, Lysiane Marthey, Michael Collins, Nathalie Chaput, Caroline Robert, Franck Carbonnel. Gut 2018
104
16

Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18FDG PET-CT.
Fanny Foubert, Sébastien Gouard, Catherine Saï-Maurel, Michel Chérel, Alain Faivre-Chauvet, David M Goldenberg, Jacques Barbet, Clément Bailly, Caroline Bodet-Milin, Thomas Carlier,[...]. Oncotarget 2018
11
16

[89Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse Models.
Yun Lu, Meng Li, Adriana V F Massicano, Patrick N Song, Ameer Mansur, Katherine A Heinzman, Benjamin M Larimer, Suzanne E Lapi, Anna G Sorace. Molecules 2021
5
20

Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.
Shaoquan Zheng, Yutian Zou, Jie-Ying Liang, Weikai Xiao, Anli Yang, Tiebao Meng, Shilin Lu, Zhongbing Luo, Xiaoming Xie. Mol Oncol 2020
34
16

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab.
Elaine M Jagoda, Olga Vasalatiy, Falguni Basuli, Ana Christina L Opina, Mark R Williams, Karen Wong, Kelly C Lane, Steve Adler, Anita Thein Ton, Lawrence P Szajek,[...]. Mol Imaging 2019
34
16

Triple Negative Breast Cancer: A Tale of Two Decades.
Arwa M Ali, Jawaher A K Ansari, Nashwa M Abd El-Aziz, Waleed N Abozeed, Ahmed M Abdel Warith, Khalid Alsaleh, Jean-Marc Nabholtz. Anticancer Agents Med Chem 2017
26
16

Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.
Benjamin M Larimer, Eric Wehrenberg-Klee, Frank Dubois, Anila Mehta, Taylor Kalomeris, Keith Flaherty, Genevieve Boland, Umar Mahmood. Cancer Res 2017
150
16

The breast tumor microenvironment: role in cancer development, progression and response to therapy.
Suruchi Mittal, Nicola J Brown, Ingunn Holen. Expert Rev Mol Diagn 2018
62
16

TNF in the era of immune checkpoint inhibitors: friend or foe?
Allen Y Chen, Jedd D Wolchok, Anne R Bass. Nat Rev Rheumatol 2021
30
16

Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis.
Shanawaz M Ghouse, Hong-My Nguyen, Praveen K Bommareddy, Kirsten Guz-Montgomery, Dipongkor Saha. Front Oncol 2020
20
16

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer.
Yi Xiao, Ding Ma, Shen Zhao, Chen Suo, Jinxiu Shi, Meng-Zhu Xue, Miao Ruan, Hai Wang, Jingjing Zhao, Qin Li,[...]. Clin Cancer Res 2019
131
16

Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.
Jeffrey S Weber, Geoff Gibney, Ryan J Sullivan, Jeffrey A Sosman, Craig L Slingluff, Donald P Lawrence, Theodore F Logan, Lynn M Schuchter, Suresh Nair, Leslie Fecher,[...]. Lancet Oncol 2016
228
16

Granzyme B PET Imaging of the Innate Immune Response.
Kathleen M Capaccione, Mikhail Doubrovin, Nikunj Bhatt, Akiva Mintz, Andrei Molotkov. Molecules 2020
4
25

Combining TNF blockade with immune checkpoint inhibitors in patients with cancer.
Anne Montfort, Mathieu Virazels, Céline Colacios, Nicolas Meyer, Bruno Ségui. Nat Rev Rheumatol 2021
3
33

18F-HX4/18F-FMISO-based micro PET for imaging of tumor hypoxia and radiotherapy-associated changes in mice.
Wenjing Yu, Feng Qiao, Xiaoyu Su, Dan Zhang, Hui Wang, Jinhui Jiang, Huiqin Xu. Biomed Pharmacother 2019
5
20

In Vivo Measurement of Granzyme Proteolysis from Activated Immune Cells with PET.
Ning Zhao, Conner Bardine, André Luiz Lourenço, Yung-Hua Wang, Yangjie Huang, Simon J Cleary, David M Wilson, David Y Oh, Lawrence Fong, Mark R Looney,[...]. ACS Cent Sci 2021
8
16

An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
Richard Tavaré, Helena Escuin-Ordinas, Stephen Mok, Melissa N McCracken, Kirstin A Zettlitz, Felix B Salazar, Owen N Witte, Antoni Ribas, Anna M Wu. Cancer Res 2016
194
16

An overview of triple-negative breast cancer.
Pankaj Kumar, Rupali Aggarwal. Arch Gynecol Obstet 2016
268
16

A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer.
Johanna Wagner, Maria Anna Rapsomaniki, Stéphane Chevrier, Tobias Anzeneder, Claus Langwieder, August Dykgers, Martin Rees, Annette Ramaswamy, Simone Muenst, Savas Deniz Soysal,[...]. Cell 2019
299
16

Regulation of Immunity in Breast Cancer.
Chidalu A Edechi, Nnamdi Ikeogu, Jude E Uzonna, Yvonne Myal. Cancers (Basel) 2019
22
16


Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells.
Debangshu Samanta, Youngrok Park, Xuhao Ni, Huili Li, Cynthia A Zahnow, Edward Gabrielson, Fan Pan, Gregg L Semenza. Proc Natl Acad Sci U S A 2018
147
16

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
16

Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40.
David J Messenheimer, Shawn M Jensen, Michael E Afentoulis, Keith W Wegmann, Zipei Feng, David J Friedman, Michael J Gough, Walter J Urba, Bernard A Fox. Clin Cancer Res 2017
173
16

Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents.
Matteo Santoni, Emanuela Romagnoli, Tiziana Saladino, Laura Foghini, Stefania Guarino, Marco Capponi, Massimo Giannini, Paolo Decembrini Cognigni, Gerardo Ferrara, Nicola Battelli. Biochim Biophys Acta Rev Cancer 2018
88
16



Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer.
Emma Nolan, Peter Savas, Antonia N Policheni, Phillip K Darcy, François Vaillant, Christopher P Mintoff, Sathana Dushyanthen, Mariam Mansour, Jia-Min B Pang, Stephen B Fox,[...]. Sci Transl Med 2017
161
16

Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis.
Yuan Yang, Howard H Yang, Ying Hu, Peter H Watson, Huaitian Liu, Thomas R Geiger, Miriam R Anver, Diana C Haines, Philip Martin, Jeffrey E Green,[...]. Oncotarget 2017
46
16

FDG PET/CT in infection and inflammation--current and emerging clinical applications.
S Vaidyanathan, C N Patel, A F Scarsbrook, F U Chowdhury. Clin Radiol 2015
155
16

Chemotherapy-induced changes and immunosenescence of CD8+ T-cells in patients with breast cancer.
Oscar Okwudiri Onyema, Lore Decoster, Rose Njemini, Louis Nuvagah Forti, Ivan Bautmans, Marc De Waele, Tony Mets. Anticancer Res 2015
32
16

Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy?
Lubna N Chaudhary, K Hope Wilkinson, Amanda Kong. Surg Oncol Clin N Am 2018
49
16

Role of the Tumor Microenvironment in Breast Cancer.
Savas D Soysal, Alexandar Tzankov, Simone E Muenst. Pathobiology 2015
173
16

Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model.
Benjamin B Kasten, Hailey A Houson, Jennifer M Coleman, Jianmei W Leavenworth, James M Markert, Anna M Wu, Felix Salazar, Richard Tavaré, Adriana V F Massicano, G Yancey Gillespie,[...]. Sci Rep 2021
6
16

Blocking Tumor Necrosis Factor α Enhances CD8 T-cell-Dependent Immunity in Experimental Melanoma.
Florie Bertrand, Julia Rochotte, Céline Colacios, Anne Montfort, Anne-Françoise Tilkin-Mariamé, Christian Touriol, Philippe Rochaix, Isabelle Lajoie-Mazenc, Nathalie Andrieu-Abadie, Thierry Levade,[...]. Cancer Res 2015
59
16

Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.
Kha-Liang Lee, Yung-Che Kuo, Yuan-Soon Ho, Yen-Hua Huang. Cancers (Basel) 2019
89
16

Comparison of Immuno-PET of CD138 and PET imaging with 64CuCl2 and 18F-FDG in a preclinical syngeneic model of multiple myeloma.
Clément Bailly, Sébastien Gouard, Marie Lacombe, Patricia Remaud-Le Saëc, Benjamin Chalopin, Mickaël Bourgeois, Nicolas Chouin, Raphaël Tripier, Zakaria Halime, Ferid Haddad,[...]. Oncotarget 2018
19
16

Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading.
Jeremy Force, Jorge Henrique Santos Leal, Heather L McArthur. Curr Treat Options Oncol 2019
35
16

Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database.
Magdalena L Plasilova, Brandon Hayse, Brigid K Killelea, Nina R Horowitz, Anees B Chagpar, Donald R Lannin. Medicine (Baltimore) 2016
88
16

In vivo characterization of PD-L1 expression in breast cancer by immuno-PET with 89Zr-labeled avelumab.
Miao Li, Emily B Ehlerding, Dawei Jiang, Todd E Barnhart, Weiyu Chen, Tianye Cao, Jonathan W Engle, Weibo Cai. Am J Transl Res 2020
10
16

Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model.
Sadiya Parveen, Sumit Siddharth, Laurene S Cheung, Alok Kumar, Jessica Shen, John R Murphy, Dipali Sharma, William R Bishai. Mol Oncol 2021
7
16

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors.
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué, Laurence Zitvogel, Guido Kroemer. Nat Rev Clin Oncol 2020
244
16

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
16

Triple-negative breast cancer: an unmet medical need.
Clifford A Hudis, Luca Gianni. Oncologist 2011
530
16

Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis.
Jimmy Ln Vo, Lirong Yang, Samantha L Kurtz, Sean G Smith, Bhanu Prasanth Koppolu, Sruthi Ravindranathan, David A Zaharoff. Oncoimmunology 2015
19
16

Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Peter Schmid, Hope S Rugo, Sylvia Adams, Andreas Schneeweiss, Carlos H Barrios, Hiroji Iwata, Véronique Diéras, Volkmar Henschel, Luciana Molinero, Stephen Y Chui,[...]. Lancet Oncol 2020
438
16

Examining Immunotherapy Response Using Multiple Radiotracers.
Julian L Goggi, Siddesh V Hartimath, Youyi Hwang, Yun Xuan Tan, Shivashankar Khanapur, Boominathan Ramasamy, Lingfan Jiang, Fui Fong Yong, Peter Cheng, Peng Wen Tan,[...]. Mol Imaging Biol 2020
13
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.